| Term 
 
        | what is the general order for tx htn 12 |  | Definition 
 
        | thiazide diruetic ACE inhibitor / ARB
 CCB
 BB
 other: renin inhibitor, ALD receptor antagonist, a1 adrenergic blocker, a2 agonist, peripherial adrenergic blockers, non-specific adrenergic blockers, vasodilators
 |  | 
        |  | 
        
        | Term 
 
        | what is the general order for tx of CHF 10 |  | Definition 
 
        | ACEI/ARB BB: metaprolol, bisprolol
 Non-specific BB: carvedilol
 amlodipiine
 hydralazine
 inotropic: B agonist, phosphodiesterase inhibitor, nesiritide, digitalis
 |  | 
        |  | 
        
        | Term 
 
        | explain the theatment of eldelry of AA with HTN 2 |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | explain the TX of HTN post MI 2 |  | Definition 
 
        | 24h: ACEI maintain: ARB, BB
 |  | 
        |  | 
        
        | Term 
 
        | explain the TX of HTN in pt with renal failure 1 |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | explain TX of HTN in pt with DM 1 |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | explain TX of HTN in pregnant pt |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | explain TX of HTN in pt with renal HTN |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | what is #1 and #2 choice for acute HTN |  | Definition 
 
        | 1. sodium nutroprusside 2. non-specific adrenergic blockers (labelalol, carvedilol)
 |  | 
        |  | 
        
        | Term 
 
        | explain TX of HTN in pt with asthma or peripherial vascular disease |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | what HTN drugs can tx diabetic nephropathy 2 |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | ther than HTN what can BB treat 4 |  | Definition 
 
        | hyperthyroid migraine prophylaxia
 glaucoma
 cardiomyopathy
 |  | 
        |  | 
        
        | Term 
 
        | other than HTN what can a1 adrenergic blocker tx |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | what than HTN what vasodilator has another use, what is it |  | Definition 
 
        | minoxidil: topical male pattern baldness |  | 
        |  | 
        
        | Term 
 
        | what drug do you use in CHF renal failure pt (#1 and #2) |  | Definition 
 
        | DOC: ACEI/ARB 2: hydralazine
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | chlorthalidone hydrochlorothiazide
 |  | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 
        | 2 ARN (ANGII receptor blocker) |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | 3 CCB, which can be used for CHF |  | Definition 
 
        | verapamil diatiazem
 amlodipine - CHF and HTN
 |  | 
        |  | 
        
        | Term 
 
        | explain naming of BB, which can be used in CHF |  | Definition 
 
        | A-M B1 selective -olol N-Z B1/2 non-selective -olol
 metapropolol
 bispropolol
 |  | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 
        | 2 ALD receptor antagonist |  | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 
        | prazosin terazosin
 doxazosin
 |  | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 
        | 1 peripherial adrenergic blocker |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | 2 non-specific adrenergic blockers, which is used in CHF |  | Definition 
 
        | labetalol carvedilol - CHF and HTN
 |  | 
        |  | 
        
        | Term 
 
        | 4 vasodilators, which can be used for CHF |  | Definition 
 
        | hydralazine - CHF and HTN minoxidil
 Na nitroprusside
 isorbide dinitrate
 |  | 
        |  | 
        
        | Term 
 
        | 4 categories of inotropic drugs |  | Definition 
 
        | B adrenergic antagonist phosphodiesterase inhibitor
 nesiritide
 digitalis
 |  | 
        |  | 
        
        | Term 
 
        | 1 B adrenergic antagonist |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | 2 phosphodiesterase inhibitor |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | what is nesiritide made of |  | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 
        | stops electrolyte transport causing Na/water excretion 
 decreases BV, CO and BO
 increases urine output
 
 urineoutput, CO, and BV return to normal in days but BP stays fixed due to vascular reactivity to NE and secreased structural resistance
 
 overall: DECREASES PRELOAD
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | stops conversion of ANGI to ANGII and bradyinin to inactive 
 causes vasodilation: inc preload and afterload
 water/NA excretion: dec preload
 prevents ALD cardiac remodel
 
 stops renin feedback and renin builds up
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | stops ATI receptors so ANGII can't activate ALD or vasoconstrict 
 vasodilation: dec preload and afterload
 water/Na excretion: dec preload
 stops cardiac remodeling
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | block L Ca channels in HEART MUSCLE slowing phase 4/0 at AV 
 decreases CO, increases PR, negative inotropic
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | blocks L Ca channel in VESSELS AND HEART causing vasodilation and dec CO |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | block L Ca channels in VESSELS causing vasodilation most likley to cause reflex tachycardia
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | antagonize B1 on heart dec CO antagonize B1 on JG decreasing renin
 
 vasodilation
 Na/water excretion
 stops cardiac remodeling - some...
 
 improves symptoms, exercise tolerance
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | low dose, build over 4-5 wks |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | stops conversion of angiotensinogen to ANG I 
 vasodilation
 Na/water excretion
 stoms cardiac remodeling - some...
 increased renin due to loss of neg feedback
 |  | 
        |  | 
        
        | Term 
 
        | MOA ALD receptor antagonist |  | Definition 
 
        | K sparing diruetics (not awesome diruetics) block ALD which causes K wasting 
 cause Na/water excretion decreasing preload
 |  | 
        |  | 
        
        | Term 
 
        | MOA a1 adrenergic blockers |  | Definition 
 
        | block a1 on ARTERIOLES AND VEINS causing vasodilation |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | decrease sympathetic outflow from brainstem vasopressors (main regulator of Na retention) |  | 
        |  | 
        
        | Term 
 
        | MOA peripherial adrenergic blockers |  | Definition 
 
        | blocks reuptake of NE/E causig depletion and decreased SNS 
 vasodilation, dec CO
 |  | 
        |  | 
        
        | Term 
 
        | MOA non-specific adrenergic blockers |  | Definition 
 
        | block A1, B1, B2 decrease TPR without reflex tachycardia
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | NO causes ARTERIOLE dilation (increases flow most) |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | opens K channels hypopolarizing, dilates ARTERIOLES |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | NO dilates VEINS AND ARTERIES |  | 
        |  | 
        
        | Term 
 
        | administration Na nitroprusside |  | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 
        | VENOdilator, decreases proload |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | B adrenergic antagonist: dobutamine, dopanine pisphodiesterase inhibitor: inamirone, milrone
 |  | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 
        | antagonize B1 and increase CO |  | 
        |  | 
        
        | Term 
 
        | administration dobutamine |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | administration of dopamine and effect |  | Definition 
 
        | <2ug/kg: D1 vasodilate renal 2-5ug/kg: V1 inc CO
 5015ug/kg: A1 vasoconstrict, inc TPR
 |  | 
        |  | 
        
        | Term 
 
        | MOA phosphodiesterase inhibitor |  | Definition 
 
        | increase cAMP, phosphorlyates Ca channel increases CO
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | vasodilate veins and arteries |  | 
        |  | 
        
        | Term 
 
        | MOA digtaliz and digitoxin |  | Definition 
 
        | reversibly bind Na/K ATPase chances Ca/Na channel
 Ca comes in
 increases CO
 decreases SNS, TPR
 |  | 
        |  | 
        
        | Term 
 
        | what is the difference between digitalis and digitoxin |  | Definition 
 
        | digitoxin: t1/2: 15d digitalis: t1/2: 48h
 
 toxin is more toxic
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | K depletion (restrict Na intake) increased glucose (don't DC if become diabetic)
 |  | 
        |  | 
        
        | Term 
 
        | interactions thiazide diruetics, why |  | Definition 
 
        | digitallis: messes with Na/K ATPase |  | 
        |  | 
        
        | Term 
 
        | contraindications thiazide diruetics 3, why |  | Definition 
 
        | DM: increases glucose chronic arrhythmia, acute MI: messes with K
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | catopril cough: due to brady build up angioedema: face and mouth
 teratogenic
 acute renal failure
 |  | 
        |  | 
        
        | Term 
 
        | why does ACEI cause acute renal failure |  | Definition 
 
        | ANG II constricts efferent arteriole when renal perfusion is low (never use in bilateral renal artery stenosis) |  | 
        |  | 
        
        | Term 
 
        | interactions/contraindications ACEI 2 |  | Definition 
 
        | never use with ARB dont use in renal artery tenosis
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | teratogenic acute renal failure
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | constipation dizzy
 naturitic
 |  | 
        |  | 
        
        | Term 
 
        | interactions/contrindications of verpamil 3 |  | Definition 
 
        | no diruetic: its a naturitic no CHF
 no BB
 |  | 
        |  | 
        
        | Term 
 
        | interactions/contrindications of dialtiazem 3 |  | Definition 
 
        | no diruetic: its a naturitic no CHF
 no BB
 |  | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 
        | gingival hyperplasia dizzy
 reflex tachycardia
 |  | 
        |  | 
        
        | Term 
 
        | contraindications amlodipine |  | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 
        | inc LDL and TG withdrawl: rebount HTN
 hypotension
 bradycardia
 decreased lobido, lethargy
 
 B2: bronchoconstriction, increases glucose
 |  | 
        |  | 
        
        | Term 
 
        | contraindications to BB 2 |  | Definition 
 
        | dont use non-selective in asthmatic or diabetic |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | slight cough angioedema
 teratopenic
 |  | 
        |  | 
        
        | Term 
 
        | SE ALD receptor antagonist |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | contraindications to ALD receptor antagonist 2 |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | how can you prevent hyperkalemia in ALD receptor antagonist |  | Definition 
 
        | use in combo with ACRI/ARB |  | 
        |  | 
        
        | Term 
 
        | SE a1 adrenergic blocker 2 |  | Definition 
 
        | postural HTN on 1st dose dizzy
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | sedation dry mouth
 withdrawl: rebound HTN
 hemolytic anemia - methyldopa
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | sedation bradycardia
 depression
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | bronchoconstriction arrhythmia (C blockade)
 dec lobido
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | lupus like in slow acetylators reflex tachycardia
 |  | 
        |  | 
        
        | Term 
 
        | SE Na nitroprusside, why 2 |  | Definition 
 
        | hypotension metabolized to cyanide
 |  | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 
        | anorexia, nausea, vomiting, headache, fatigue, confusion, blurred yellow vision |  | 
        |  | 
        
        | Term 
 
        | digitalis toxicity signs 8, why |  | Definition 
 
        | Ca overload increases automaticity causing DAD leading to ... increased systole
 tachycardia
 PVC
 fibrillation
 complete block
 VTac
 VFib
 |  | 
        |  | 
        
        | Term 
 
        | things that cause predisposition to digitalis toxicity 4 |  | Definition 
 
        | hypoklemia: arrhythmia wuinidine and verapamil: displace it
 diuretics: increase its binding
 |  | 
        |  |